516561 Sigma-AldrichPertussis Toxin, Bordetella pertussis, Glycerol Solution - CAS 70323-44-3 - Calbiochem
Pertussis Toxin, Bordetella pertussis, Glycerol Solution, CAS 70323-44-3, is a protein endotoxin that catalyzes ADP-ribosylation of guanine nucleotide-binding regulatory proteins.
More>> Pertussis Toxin, Bordetella pertussis, Glycerol Solution, CAS 70323-44-3, is a protein endotoxin that catalyzes ADP-ribosylation of guanine nucleotide-binding regulatory proteins. Less<<Synonyms: Islet-activating Protein
Recommended Products
개요
| Replacement Information |
|---|
주요 사양표
| CAS # |
|---|
| 70323-44-3 |
가격 및 재고여부
| 카탈로그 번호 | 재고 정보 | 패킹 | 포장 단위 | 가격(VAT 별도) | 수량 | |
|---|---|---|---|---|---|---|
| 516561-50UGCN |
|
Alu drum | 50 μg |
|
— |
| Product Information | |
|---|---|
| CAS number | 70323-44-3 |
| ATP Competitive | N |
| Form | Liquid |
| Formulation | In 500 mM NaCl, 50 mM Tris, 10 mM glycine, 50% glycerol, pH 7.5. |
| Reversible | N |
| Quality Level | MQ200 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Contaminants | Adenylate cyclase. |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | XW5883750 |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 카탈로그 번호 | GTIN |
| 516561-50UGCN | 04055977198171 |
Documentation
Pertussis Toxin, Bordetella pertussis, Glycerol Solution - CAS 70323-44-3 - Calbiochem MSDS
| 타이틀 |
|---|
Pertussis Toxin, Bordetella pertussis, Glycerol Solution - CAS 70323-44-3 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 516561 |
References
| 참고문헌 보기 |
|---|
| Fryer, M.W. 1992. Neurosci. Lett. 146, 84. Gierschik, P. 1992. Curr. Topics Microbiol. Immunol. 175, 69. Harada, J., et al. 1992. Eur. J. Pharmacol. 227, 301. Hausman, S.Z., and Burns, D.L. 1992. J. Biol. Chem. 267, 13735. Kaslow, H.R., and Burns, D.L. 1992. FASEB J. 6, 2684. Zhu, J., et al. 1992. J. Pharmacol. Exp. Therap. 263, 1479 Kaslow, H.R., et al. 1987. Biochemistry 26, 123. Hewlett, E.L., et al. 1983. Infect. Immun. 40, 1198. Moss, J., et al. 1983. J. Biol. Chem. 258, 11879. |



